Skip to main content

Groundbreaking Science.

Life-Changing Medicines.

Groundbreaking Science.

Life-Changing Medicines.

At Scripps Research, we believe science can transform human health worldwide. We combine the best of nonprofit fundamental research and drug discovery to accelerate the impact of scientific advances on patients.

  • 6 Nobel Prizes
  • Top 5 Biomedical Institutes in the World
  • #1 Ranked Graduate School in Biological Sciences
  • 18 FDA Approved Drugs

What can we help you find?

highly cited researchers 2026
News

Seven Scripps Research scientists named to Clarivate’s 2026 list of Highly Cited Researchers

Christian Diercks and Danielle Grotjahn. Credit: Scripps Research
News

Two Scripps Research faculty named inaugural recipients of the Schultz Innovative Investigator Award

Renan V.H. de Carvalho
News

NIH awards $7 million to study what makes immune responses last

Members of the Law and Park labs during the recent International Symposium on Hepatitis C Virus, Flaviviruses and Related Viruses in Copenhagen. From left: Fang Chen, Yukiye Koide, Joseph Cruz, and Mansun Law.
News

NIH awards $16.4 million to establish multi-institution hepatitis C vaccine development center

The Front Row lecture series: Darrell Irvine, PhD
News

The Front Row lecture series: Darrell Irvine, PhD

Enter curious, leave informed.

Celebrate the journey: Graduation Day 2026
Video

Celebrate the journey: Graduation Day 2026

Hear from 3 of our newest PhD recipients as they reflect on their experience as students in Scripps Research’s Skaggs Graduate School. The students are among the 49 who were awarded doctoral degrees at the institute’s May 15th Commencement.

Graduate Program
scripps research science changing life podcast episode 57
Podcast

What’s next for IBD care: Insights from a surgeon-scientist

The data is clear: inflammatory bowel diseases like ulcerative colitis and Crohn’s are on the rise worldwide. In this episode, we sit down with Dr. Amy Lightner—VP of Clinical Development at Calibr-Skaggs and colorectal surgeon at Scripps Clinic—to explore what drives these diseases, an upcoming phase 2 clinical trial for a new regenerative medicine, and how she balances life between the operating room and the research lab.

Translational Medicine Calibr-Skaggs Drug Discovery Crohn’s disease Inflammatory bowel disease
amy lightner lab
Magazine

The new guidelines for ulcerative colitis mean fewer surgeries—and fewer colonoscopies

Dr. Amy Lightner has spent her career moving between the operating room and the research lab, treating ulcerative colitis (UC) and other inflammatory bowel disease (IBD) patients as a surgeon while also searching for better treatments as a scientist.

Science Changing Life.
Life-changing Medicine.